|

Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

RECRUITINGN/ASponsored by Stanford University
Actively Recruiting
PhaseN/A
SponsorStanford University
Started2026-06-24
Est. completion2027-09-15
Eligibility
Age5 Years – 14 Years
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT07155707

Summary

This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Eligibility

Age: 5 Years – 14 YearsHealthy volunteers accepted
Inclusion Criteria:

* Diagnosed with a mood and/or anxiety disorder
* Have proficiency to participate in psychotherapy in English
* Scheduled to begin therapy at one of the study sites
* RCADS score \> 65

Exclusion Criteria:

\- Comorbid diagnosis of intellectual disability, autism spectrum disorder, psychotic disorders, high-risk suicidal behaviors requiring immediate hospitalization, substance use disorders, or other physical or mental condition that would prohibit them from engaging in telehealth settings.

Conditions3

AnxietyDepressionMood Disorders

Locations2 sites

Ohana Center for Child and Adolescent Behavioral Health
Monterey, California, 93940
Stanford University
Stanford, California, 94305
David S Hong, MD650-724-2939dshong@stanford.edu

Find trials near these locations

All trials in California

Browse More Trials

Depression trialsAnxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.